More about

Epstein Barr Virus Infection

News
April 03, 2025
2 min read
Save

‘Distinct viral exposure patterns’ found in patients with Crohn’s years before diagnosis

Patients with Crohn’s disease had high Epstein-Barr virus seropositivity in the preclinical period and at diagnosis of inflammatory bowel disease, according to results of a cohort study of military personnel published in Gastroenterology.

Clinical Guidance
Multiple Sclerosis
Assessment and Treatment

Assessment of Multiple Sclerosis

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Multiple Sclerosis
Overview

Etiology and Risk Factors

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News
March 29, 2024
2 min read
Save

Moderna announces positive interim results for next-generation COVID-19 vaccine

Moderna announced positive interim results from a phase 3 trial of its next-generation COVID-19 vaccine, which the company said will help pave the way for its combination shot against COVID-19 and influenza.

News
March 20, 2024
3 min read
Save

Valaciclovir safe, efficacious for Epstein-Barr virus suppression in COPD

Among patients with COPD and sputum Epstein-Barr virus, valaciclovir three times a day for 8 weeks helped more individuals suppress the virus than placebo, according to study results published in CHEST.

News
February 24, 2023
1 min read
Save

Recent evidence supports Epstein-Barr virus as ‘leading cause’ of MS

SAN DIEGO — Evidence over the past 10 years supports the role of Epstein-Barr virus in the development of MS, according to a presenter at ACTRIMS 2023.

News
November 02, 2022
2 min read
Save

Top news of October: Probiotics, COVID-19 vaccines, Epstein-Barr virus, more

Healio compiled the most-read news in allergy, asthma and immunology posted in October.

News
October 24, 2022
2 min read
Save

Epstein-Barr virus reactivation may contribute to long COVID fatigue

Epstein-Barr virus replication may be a cofactor in a subgroup of patients who develop long COVID fatigue, although other potential contributing factors need to be evaluated as well, according to a letter published in Allergy.

News
January 28, 2022
1 min read
Save

Top neuro stories of January: FDA developments, Medicare proposal limits Aduhelm coverage

Healio’s most-viewed neurology stories in January highlight several FDA developments, a Medicare proposal to limit Aduhelm coverage and a study on the role of Epstein-Barr virus infection in MS.

News
January 19, 2022
2 min read
Save

Epstein-Barr virus may be ‘initial trigger’ of MS

Epstein-Barr virus infection, which causes mononucleosis, may represent a primary cause of MS, according to results of a longitudinal analysis published in Science.

View more